Frontiers in Immunology (Mar 2022)
Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
- Jiawen Zhang,
- Peiyu Jiang,
- Lei Sheng,
- Yunyi Liu,
- Yixuan Liu,
- Min Li,
- Meng Tao,
- Liang Hu,
- Xiaoyan Wang,
- Yanjing Yang,
- Yang Xu,
- Wentao Liu
Affiliations
- Jiawen Zhang
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Peiyu Jiang
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Lei Sheng
- Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
- Yunyi Liu
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Yixuan Liu
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Min Li
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Meng Tao
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Liang Hu
- Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
- Xiaoyan Wang
- Department of Dermatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
- Yanjing Yang
- Jiangsu Key Laboratory of Oral Disease, Nanjing Medical University, Nanjing, China
- Yang Xu
- Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
- Wentao Liu
- Jiangsu Key Laboratory of Neurodegeneration, Department of Pharmacology, Nanjing Medical University, Nanjing, China
- DOI
- https://doi.org/10.3389/fimmu.2022.881277
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
